TRxADE HEALTH Inc. (MEDS) Financial Statements (2025 and earlier)

Company Profile

Business Address 2420 BRUNELLO TRACE
LUTZ, FL 33558
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,7203,499152347461,194
Cash and cash equivalents7,7203,499152347461,194
Receivables2,24410,3482,1222,125799708
Inventory, net of allowances, customer advances and progress billings6513,027161126
Inventory6513,027161126
Prepaid expense 797174108246389358
Deferred costs69     
Disposal group, including discontinued operation7     
Other undisclosed current assets1,300 371116  
Total current assets:12,14414,0272,7535,5482,0952,386
Noncurrent Assets
Operating lease, right-of-use asset1761835301,1889521,002
Property, plant and equipment772772886062
Long-term investments and receivables2,5002,500    
Long-term investments2,5002,500    
Intangible assets, net (including goodwill), including:  8,96314,581590538
Goodwill   5,129  
Intangible assets, net (excluding goodwill)  8,9639,452  
Other undisclosed intangible assets, net (including goodwill)     590538
Deposits noncurrent assets222211494949
Total noncurrent assets:2,7042,7129,78016,1061,6501,652
TOTAL ASSETS:14,84916,73912,53321,6543,7454,038
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,2271,4462,4831,7151,240819
Accounts payable7269532,0821,329864516
Accrued liabilities500493401386376303
Debt   6,5305,230  
Derivative instruments and hedges, liabilities     1,957509
Disposal group, including discontinued operation5     
Other liabilities5570412792229
Other undisclosed current liabilities1,6651,4992,4731,735274993
Total current liabilities:2,9022,95111,5569,0924,2632,550
Noncurrent Liabilities
Long-term debt and lease obligation  2525  
Long-term debt, excluding current maturities  2525  
Liabilities, other than long-term debt161169409977777832
Other liabilities     777832
Operating lease, liability161169409977  
Other undisclosed noncurrent liabilities      
Total noncurrent liabilities:1611694341,002777832
Total liabilities:3,0633,12011,99110,0945,0403,383
Equity
Equity, attributable to parent11,78513,61954211,560(1,295)655
Common stock000000
Additional paid in capital38,29038,29033,78833,09020,58620,560
Accumulated deficit(26,505)(24,671)(33,246)(21,530)(21,880)(19,905)
Total equity:11,78513,61954211,560(1,295)655
TOTAL LIABILITIES AND EQUITY:14,84916,73912,53321,6543,7454,038

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues19 2,3522,0582,2512,248
Cost of revenue
(Cost of Goods and Services Sold)
(19) (4,601)(353)(606)(691)
Gross profit:(1) (2,249)1,7051,6451,557
Operating expenses(1,495)(5,496)(3,944)(2,550)(1,990)(1,904)
Operating loss:(1,496)(5,496)(6,193)(845)(346)(347)
Nonoperating income (expense)(129)(1,140)(5,523)674(1,629)22
Other nonoperating income      4
Interest and debt expense(5) (703)(252)(181)(62)
Loss from continuing operations before income taxes:(1,630)(6,637)(12,419)(423)(2,156)(388)
Other undisclosed income from continuing operations5     
Loss from continuing operations:(1,625)(6,637)(12,419)(423)(2,156)(388)
Income (loss) from discontinued operations(209)27,883 (3,354) (352)
Other undisclosed net income  70325218162
Net income (loss) available to common stockholders, diluted:(1,834)21,246(11,716)(3,525)(1,975)(678)

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net income (loss):(1,834)21,246(11,716)(3,525)(1,975)(678)
Comprehensive income (loss), net of tax, attributable to parent:(1,834)21,246(11,716)(3,525)(1,975)(678)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: